熱門資訊> 正文
Sanuwave通过新的信贷安排对债务进行再融资
2025-09-26 22:46
- Sanuwave Health (NASDAQ:SNWV) has announced the refinancing of its $27.5M debt facility with a $23.0M new secured credit facility from J.P. Morgan, 1.0M withdrawn from a two-year $5.0M revolving credit facility, and the remainder was repaid using cash accumulated from the company’s operations and from its sale of certain intravascular shockwave patents.
- The $23.0M loan will amortize over a four-year period, and a two-year $5.0M receivables are backed by a revolving credit facility.
- The new credit facility will have an interest rate of SOFR (Secured Overnight Financing Rate) +350bp and neither facility has any prepayment penalties.
More on SANUWAVE Health
- Sanuwave: A Long-Term Compounder In Its Early Stages
- SANUWAVE Health, Inc. 2025 Q2 - Results - Earnings Call Presentation
- SANUWAVE Health, Inc. (SNWV) Q2 2025 Earnings Call Transcript
- Sanuwave Health rises after $5M payment related to patent sale
- SANUWAVE outlines Q3 revenue target of $12M–$12.7M as new applicator production nears launch
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。